Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's
disease (CD), is characterized by relapse and remission alternately. It remains a great …

OBJECTIVES: In 2015, the Selecting Therapeutic Targets in Inflammatory Bowel Disease
(STRIDE) program proposed shifting the therapeutic focus on ulcerative colitis (UC) toward …

Background The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)
initiative of the International Organization for the Study of Inflammatory Bowel Diseases …

Inflammatory bowel disease is a progressive and debilitating condition. Early and effective
treatment utilizing a treat to target approach is key in improving patient outcomes. Therefore …

Calprotectin is a 36 kDa member of the S100 family of proteins. It is derived predominantly
from neutrophils and has direct antimicrobial effects and a role within the innate immune …

Inflammatory bowel disease (IBD) denotes a group of chronic incurable disorders
characterized by relapsing-remitting inflammation of the gastrointestinal tract. IBD represents …

Background: A low fermentable oligosaccharides, disaccharides, monosaccharides, and
polyols diet (LFD) is claimed to improve functional gastrointestinal symptoms (FGSs) …

Fecal calprotectin (FC) levels correlate with the disease activity of inflammatory bowel
diseases (IBD); however, the utility of FC in predicting IBD relapse remains to be …

Background Inflammatory bowel disease (IBD) follows a heterogenous disease course and
predicting a patient's prognosis is challenging. There is a wide burden of illness in IBD and …

Abstract Background and Aims Inflammatory bowel disease [IBD], consisting of Crohn's
disease [CD] and ulcerative colitis [UC], is a relapsing-remitting illness. Treat-to-target IBD …